(HTEC) Robo Global Healthcare - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US3015057231 • Health
HTEC: Medical, Devices, Software, Diagnostics, Robotics, Equipment
The fund will normally invest at least 80% of its total assets in securities of the index or in depositary receipts representing securities of the index. The index is designed to measure the performance of companies that have a portion of their business and revenue derived from the field of healthcare technology, and the potential to grow within this space through innovation and market adoption of such companies' products and services. It is non-diversified.
Additional Sources for HTEC ETF
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
HTEC ETF Overview
| Market Cap in USD | 50m |
| Category | Health |
| TER | 0.68% |
| IPO / Inception | 2019-06-24 |
HTEC ETF Ratings
| Growth 5y | 1.63% |
| Fundamental | - |
| Dividend | 1.0% |
| Rel. Strength Industry | -58.7 |
| Analysts | - |
| Fair Price Momentum | 27.77 USD |
| Fair Price DCF | - |
HTEC Dividends
| Dividend Yield 12m | 0.00% |
| Yield on Cost 5y | % |
| Annual Growth 5y | -100.00% |
| Payout Consistency | 1.0% |
HTEC Growth Ratios
| Growth Correlation 3m | 36.8% |
| Growth Correlation 12m | 73.5% |
| Growth Correlation 5y | -48.4% |
| CAGR 5y | 2.54% |
| CAGR/Mean DD 5y | 0.09 |
| Sharpe Ratio 12m | 0.44 |
| Alpha | -17.08 |
| Beta | 1.07 |
| Volatility | 20.25% |
| Current Volume | 20k |
| Average Volume 20d | 9.1k |
What is the price of HTEC stocks?
As of January 23, 2025, the stock is trading at USD 30.74 with a total of 20,000 shares traded.
Over the past week, the price has changed by +4.99%, over one month by +5.59%, over three months by +6.78% and over the past year by +11.18%.
As of January 23, 2025, the stock is trading at USD 30.74 with a total of 20,000 shares traded.
Over the past week, the price has changed by +4.99%, over one month by +5.59%, over three months by +6.78% and over the past year by +11.18%.
Is Robo Global Healthcare a good stock to buy?
Neither. Based on ValueRay Analyses, Robo Global Healthcare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.63 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HTEC as of January 2025 is 27.77. This means that HTEC is currently overvalued and has a potential downside of -9.66%.
Neither. Based on ValueRay Analyses, Robo Global Healthcare is currently (January 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 1.63 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of HTEC as of January 2025 is 27.77. This means that HTEC is currently overvalued and has a potential downside of -9.66%.
Is HTEC a buy, sell or hold?
Robo Global Healthcare has no consensus analysts rating.
Robo Global Healthcare has no consensus analysts rating.
What are the forecast for HTEC stock price target?
According to ValueRays Forecast Model, HTEC Robo Global Healthcare will be worth about 31 in January 2026. The stock is currently trading at 30.74. This means that the stock has a potential upside of +0.68%.
According to ValueRays Forecast Model, HTEC Robo Global Healthcare will be worth about 31 in January 2026. The stock is currently trading at 30.74. This means that the stock has a potential upside of +0.68%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 31 | 0.7% |